Istituto Nazionale Tumori (National Cancer Institute)

Milan 20133

0 studies enrolling now · 1 studies all time

What they study most

Solid Tumor

Studies at this site

• Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations — Completed